Searched for
PHARMACOVIGILANCE
Drug companies directed to step up vigil on adverse reactionsIndia's drug regulator, CDSCO, has mandated all drug companies to establish systems for tracking adverse drug reactions. This move comes am...- Drugmakers must report safety data from launch date, not approval date: CDSCOIndia's drug regulator has issued a new directive for pharmaceutical companies. Periodic Safety Update Reports for new drugs must now be su...
- Drug regulator cracks down on delayed safety reporting by pharma companiesIndia's drug regulator CDSCO has issued new rules for drug safety reporting. Companies must now submit safety reports from the actual launc...
- Pharma firms asked for side-effects of common medicinesIndia's drug regulator has issued new safety warnings for common medicines. Doxycycline, an antibiotic, will now list side effects like anx...
- AI and Automation Are Reshaping Drug SafetyWith the increase in volume and complexity of drug safety data, artificial intelligence is transforming the functioning of pharmacovigilanc...
- CDSCO directs pharmacies to display QR code and toll-free number for reporting adverse drug reactionsThe CDSCO has mandated that all retail and wholesale pharmacies across India must prominently display a QR code and a toll-free number. Thi...
- Graph AI raises $3 million seed funding for drug safety platformAI life sciences startup Graph AI has secured $3 million in seed funding to revolutionise pharmacovigilance. The California-based startup l...
- India ranks among top contributors in reporting adverse events: Drugs Controller General of IndiaDCGI Dr. Rajeev Raghuvanshi highlighted India's leading role in global adverse event reporting during the 5th National Pharmacovigilance We...
- Govt issues guidance paper to strengthen vaccine companies' reporting of adverse eventsThe new report released last week aims to provide guidance to the manufacturers and importers of vaccines in the country so as to strengthe...
- Lupin appoints Dr Ranjana Pathak as chief quality officerDr. Ranjana Pathak appointed Lupin's chief quality officer, succeeding Johnny Mikell. With 30 years of experience, she led quality at Cipla...
- Meftal maker says adverse reaction flagged by IPC is very rareBlue Cross Laboratories, the owner of the Meftal painkiller brand, has clarified that the adverse reaction the Indian Pharmacopoeia Commiss...
- Cabinet nod for inking MoU between India, UK for cooperation in medical product regulationThe main areas of cooperation between the two regulatory authorities include exchange of safety information, including pharmacovigilance wh...
- Official reiterates faith in HCQ, says use recommended after assessmentThe pharmacovigilance programme also monitored the use of HCQ for highrisk healthcare workers in the counrty Prophylaxis refers to treatmen...
- IPC to become first WHO Collaborating Centre in SE AsiaHealth Secretary BP Sharma said the importance of Pharmacovigilance has increased as there have been changes in the ways people take medici...
- Vigilance important to monitor adverse effects of drugs: JP NaddaHealth Minister JP Nadda today underlined the importance of pharmacovigilance, the monitoring of adverse effects of drugs in the country.
- Pharma companies may have to report drugs’ side effects to regulatorIndia is set to make it mandatory for pharmaceutical firms to report side effects of drugs to the regulator.
- Ban proposed on drugs having serious side effects"There are variations in each individual in conversions of codeine to morphine and each individual reacts differently," Prof K C Singhal.
- TCS, Cognizant, Wipro, Accenture, Genpact, HCL bite into drug safetyIndustry experts say that pharmacovigilance & clinical data management is growing at feverish pace with some pegging the growth rate at 100...
- Indian pharmaceutical industry to reach $20 bn by 2015: AssochamAssocham has said it expects the Indian pharmaceutical industry to reach $20 billion by 2015, making it one of the world's top 10 pharmaceu...
- TCS eyes deals in life sciences, healthcare spaceLife sciences and healthcare is the sixth-largest vertical for TCS and accounted for 5.2% of the firm’s revenues at the end of fiscal year ...
Load More
